Immunophenotyping and molecular studies, performed later, established a diagnosis of de novo B-cell precursor leukemia/lymphoma with <i>MYC</i>, <i>BCL2</i> rearrangements (Double-hit lymphoma). Here, MYC is linked to lymphoma.